Profound Medical (PROF) Return on Invested Capital (2024 - 2026)

Profound Medical's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.06% for Q1 2026.

• On a quarterly basis, Return on Invested Capital fell 9.0% year-over-year to 0.06% in Q1 2026; TTM through Mar 2026 was 0.06%, a 9.0% decrease from a year earlier, with the FY2024 full-year figure at 2.55%, down 248.0% from the prior year.
• Return on Invested Capital advanced to 0.06% in Q1 2026 per PROF's latest filing, from 0.08% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.03% in Q1 2025 and bottomed at 2.55% in Q4 2024.
• The 3-year median for Return on Invested Capital is 0.07% (2025), against an average of 0.48%.
• Across the five-year window, Return on Invested Capital soared 247 bps in 2025 and retreated 9 bps in 2026, its largest moves.
• Year by year, Return on Invested Capital stood at 2.55% in 2024, then surged by 97 bps to 0.08% in 2025, then rose by 27 bps to 0.06% in 2026.
• Per Business Quant, the three latest PROF Return on Invested Capital figures stand at 0.06% (Q1 2026), 0.08% (Q4 2025), and 0.07% (Q3 2025).